These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 14515796

  • 1. [Antitumor effects of the immunoconjugate composed of lidamycin and monoclonal antibody 3G11].
    Wang FQ, Shang BY, Zhen YS.
    Yao Xue Xue Bao; 2003 Jul; 38(7):515-9. PubMed ID: 14515796
    [Abstract] [Full Text] [Related]

  • 2. [Antitumor activities of various immunoconjugates composed of lidamycin and anti-type IV collagenase monoclonal antibody].
    Feng Y, Zhen YS, Dai Y, Shang BY, Zhang M, He HW, Li BW, Shao RG.
    Yao Xue Xue Bao; 2007 Jul; 42(7):704-9. PubMed ID: 17882952
    [Abstract] [Full Text] [Related]

  • 3. [Antitumor effect of lidamycin-containing monoclonal antibody immunoconjugate with downsized-molecule].
    Liu XY, Zhen YS.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):563-7. PubMed ID: 12901099
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of the antitumor activities of immunoconjugates composed of lidamycin and monoclonal antibody fab' fragment with different linkers].
    Feng Y, Shao RG, Dai Y, Li BW, He HW, Ren KH.
    Yao Xue Xue Bao; 2010 May; 45(5):571-5. PubMed ID: 20931757
    [Abstract] [Full Text] [Related]

  • 5. [Antitumor effect of the novel immunoconjugate composed of pingyangmycin and anti-type IV collagenase monoclonal antibody].
    Dai Y, Liu XJ, Zhen YS.
    Yao Xue Xue Bao; 2006 Jan; 41(1):41-6. PubMed ID: 16683526
    [Abstract] [Full Text] [Related]

  • 6. Antitumor effects of the molecule-downsized immunoconjugate composed of lidamycin and Fab' fragment of monoclonal antibody directed against type IV collagenase.
    Fengqiang W, Boyang S, Yongsu Z.
    Sci China C Life Sci; 2004 Feb; 47(1):66-73. PubMed ID: 15382678
    [Abstract] [Full Text] [Related]

  • 7. Antitumor activity of anti-type IV collagenase monoclonal antibody and its lidamycin conjugate against colon carcinoma.
    Li L, Huang YH, Li Y, Wang FQ, Shang BY, Zhen YS.
    World J Gastroenterol; 2005 Aug 07; 11(29):4478-83. PubMed ID: 16052675
    [Abstract] [Full Text] [Related]

  • 8. [Antitumor effect of the immunoconjugate composed of antibiotic C1027 and Fab fragment from a monoclonal antibody directed against human hepatoma].
    Li JZ, Jiang M, Xue YC, Zhen YS.
    Yao Xue Xue Bao; 1993 Aug 07; 28(4):260-5. PubMed ID: 8213168
    [Abstract] [Full Text] [Related]

  • 9. [Immunoscintigraphy of anti-type IV collagenase monoclonal antibody in nude mice bearing human lung cancer xenograft].
    Dai Y, Jia B, Wang F, Du J, Shang BY, Zhen YS.
    Ai Zheng; 2003 Dec 07; 22(12):1243-8. PubMed ID: 14693044
    [Abstract] [Full Text] [Related]

  • 10. Generation and antitumor effects of an engineered and energized fusion protein VL-LDP-AE composed of single-domain antibody and lidamycin.
    Miao Q, Shang B, Ouyang Z, Liu X, Zhen Y.
    Sci China C Life Sci; 2007 Aug 07; 50(4):447-56. PubMed ID: 17653664
    [Abstract] [Full Text] [Related]

  • 11. [Inhibitory effects of the immunoconjugate composed of anti-type IV collagenase antibody Fab' fragment and lidamycin on tumor invasion and metastasis].
    Feng Y, He HW, Li BW, Zhang ZX, Chen X, Li XF.
    Yao Xue Xue Bao; 2011 Dec 07; 46(12):1462-5. PubMed ID: 22375419
    [Abstract] [Full Text] [Related]

  • 12. [Biodistribution of monoclonal antibody and Fab fragment and antitumor effect of their conjugates on hepatoma xenografts].
    Li J, Zhen Y, Yang Z.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Oct 07; 16(5):328-33. PubMed ID: 7720121
    [Abstract] [Full Text] [Related]

  • 13. [Inhibitory effect of lidamycin on growth of colon carcinoma 26 and hepatic metastasis in mice].
    Liu XJ, Dai Y, Shang Y, Li Y, Zhen YS.
    Ai Zheng; 2005 Jun 07; 24(6):641-5. PubMed ID: 15946470
    [Abstract] [Full Text] [Related]

  • 14. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
    Chen J, Ouyang ZG, Zhang SH, Zhen YS.
    Oncol Rep; 2007 Jun 07; 17(6):1445-51. PubMed ID: 17487403
    [Abstract] [Full Text] [Related]

  • 15. [Use of monoclonal antibody-pinyangmycin conjugate in experimental regional targeting therapy of tumor].
    Wang WG, Xu LN, Zhang SH, Xue YC, Zhen YS.
    Yao Xue Xue Bao; 1997 Sep 07; 32(9):669-74. PubMed ID: 11596291
    [Abstract] [Full Text] [Related]

  • 16. Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule.
    Huang YH, Shang BY, Zhen YS.
    World J Gastroenterol; 2005 Jul 14; 11(26):3980-4. PubMed ID: 15996019
    [Abstract] [Full Text] [Related]

  • 17. Selective antitumor effect on L10 hepatocarcinoma cells of a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigen.
    Hwang KM, Foon KA, Cheung PH, Pearson JW, Oldham RK.
    Cancer Res; 1984 Oct 14; 44(10):4578-86. PubMed ID: 6467213
    [Abstract] [Full Text] [Related]

  • 18. Lidamycin inhibits the cancer cell PKC activity induced by basic fibroblast growth factor.
    Zhen HY, Huang YH, Zhen YS.
    Yao Xue Xue Bao; 2005 Dec 14; 40(12):1110-5. PubMed ID: 16496675
    [Abstract] [Full Text] [Related]

  • 19. [Inhibition of the growth of hepatoma and hepatic metastasis by pingyangmycin conjugated with Fab' fragment of monoclonal antibody].
    Liu X, Shang B, Liu X.
    Zhonghua Yi Xue Za Zhi; 2001 Feb 25; 81(4):201-4. PubMed ID: 11798873
    [Abstract] [Full Text] [Related]

  • 20. Antitumor effects of an engineered and energized fusion protein consisting of an anti-CD20 scFv fragment and lidamycin.
    Fang H, Miao Q, Zhang S, Cheng X, Xiong D, Zhen Y.
    Sci China Life Sci; 2011 Mar 25; 54(3):255-62. PubMed ID: 21416325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.